医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Pacific Life Re Opens New Branch and Ready to Write Onshore Reinsurance Business in Korea

2016年03月31日 AM11:05
このエントリーをはてなブックマークに追加


 

SEOUL, South Korea

Pacific Life Re Limited, Korea Branch (“Pacific Life Re Korea”) has received regulatory approval from the Financial Services Commission (FSC) to commence writing onshore reinsurance business in Korea.

Pacific Life Re Korea is part of Pacific Life Re, the reinsurance division of the Pacific Life group. Pacific Life Re has existing offices in Asia, Europe, Australia, and North America. The ultimate parent is Pacific Mutual Holding Company, a US-based mutual life insurance company founded in 1868 with over US$137bn in Company Assets, as of December 31, 2015.

“This move demonstrates our on-going commitment to further deepen our footprint in Asia,” says Alex King, Managing Director of Pacific Life Re Asia. “We have been working with our clients in Korea since 2009, operating out of our regional hub in Singapore. The recent market reforms present us with a unique opportunity to providing a fresh and innovative approach to life reinsurance in the Korean market.”

Pacific Life Re Division CEO Dave Howell also commented, “This licence represents a further expansion of the Pacific Life Re global brand and its proposition in Asia. With a local team in place, we are enhancing our service proposition to meet the needs of the Korean insurers in the coming years.”

Pacific Life Re has a financial strength credit rating from S&P and Fitch of A+ (stable outlook).

About Pacific Life Re

Pacific Life Re works with clients in the UK, Ireland, Asia, Australia, and North America to manage their mortality, longevity, and morbidity risk. Pacific Life Re Limited is a wholly-owned subsidiary of Pacific LifeCorp, and is regulated by the Prudential Regulation Authority and the Financial Conduct Authority.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160330005480/en/

CONTACT

Pacific Life Re Limited
Simon Jun Chong, +82-2-6226-7510
Head
of Korea
simon.chong@pacificlifere.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Dompé用于治疗中度或重度神经营养性角膜炎成人患者的Oxervate®(Cenegermin滴眼液)获得欧盟CHMP肯定意见
  • SCIEX Sponsored Award Recognizes Notable Contributions to Electrodriven Separations
  • LMDのV-Sensorがインドでバイタルサインを測定
  • オクタファルマ、薬物動態に基づくNuwiq®個別化予防療法(NuPreviq法)に関する新しい臨床データの発表により、血友病A患者への強いコミットメントを浮き彫りに
  • ハーバライフ・ニュートリション、健康的でアクティブな生活を促すリーダーとなれるよう、東南アジアのメンバーを鼓舞